Back to Authors

Zabransky, R.J.

Mayo Clinic

Mayo Clinic

Citations 3

Klebsiella, Enterobacter , and Serratia : Biochemical Differentiation and Susceptibility to Ampicillin and Three Cephalosporin Derivatives
Zabransky, R.J., Hall, Jack W., Day, Fred E., Needham, Gerald M.

Applied Microbiology | December 5, 2020 | Volume: 18 | Issue: 2 | Pages: 198-203

10.1128/am.18.2.198-203.1969 Get It

Three hundred twenty-nine strains of the tribe Klebsielleae were compared by several biochemical tests and by susceptibility to selected antibiotics. Biochemical tests included urease, amino acid decarboxylase, and hydrogen sulfide production; fermentation of lactose and dextrose; motility; and tests in the IMViC (indole, methyl red, Voges-Proskauer, citrate) series. The isolates were: Klebsiella species, 67.5%; Enterobacter species, 28%, and Serratia species, 4.5%. Minimal inhibitory concentrations of cephaloridine, cephalothin, and a new cephalosporin, cephalexin, and of ampicillin were determined by the agar dilution procedure. Cephalosporins at 20 μg/ml or less inhibited 90% of the Klebsiella strains but only 15% of the Enterobacter strains. Ampicillin inhibited 27% of Enterobacter strains and 17% of Klebsiella strains. Serratia isolates were insensitive to the cephalosporins and ampicillin. The results suggest that precise identification of this group to the generic level can be accomplished readily in the clinical laboratory and that such information is helpful in the preliminary selection of an antibiotic for treatment of clinical infections.
Identification of Nonfermenting Gram-negative Bacilli in the Clinical Laboratory
Zabransky, R.J., Day, Fred E.

Applied Microbiology | December 5, 2020 | Volume: 17 | Issue: 2 | Pages: 331-332

10.1128/am.17.2.331-332.1969 Get It

Pyocine Typing of Clinical Strains of Pseudomonas aeruginosa
Zabransky, R.J., Day, Fred E.

Applied Microbiology | December 5, 2020 | Volume: 17 | Issue: 2 | Pages: 293-296

10.1128/am.17.2.293-296.1969 Get It

A total of 954 clinical isolates of Pseudomonas aeruginosa were typed by their ability to produce pyocines. The strains of Pseudomonas were isolated from urines, bloods, sputa, stools, and miscellaneous infectious exudates or tissue of patients of the Mayo Clinic and four associated hospitals. About 80% of the typable strains could be grouped into three major pyocine types: A (30.9%), B (34.8%), and D (14.1%). These large groups could be divided into subtypes by using additional indicator strains. There was no significant difference in the distribution of types by either institutional or specimen source, except that urine specimens yielded the highest percentage of one type. By this procedure, 93% of all isolates could be typed. Repeated typing of serially transferred strains indicated that the procedure has a high degree of reliability. Several strains exhibited extreme fluctuation in inhibition pattern. The procedure is a simple and reliable method to monitor the patterns of nosocomial infections due to P. aeruginosa .